Cover Image
市場調查報告書

靜脈瘤的預測:主要15市場

Varicose Veins Forecast in 15 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 350712
出版日期 內容資訊 英文 60 pages
訂單完成後即時交付
價格
Back to Top
靜脈瘤的預測:主要15市場 Varicose Veins Forecast in 15 Major Markets 2015-2025
出版日期: 2015年11月30日 內容資訊: 英文 60 pages
簡介

本報告提供主要15個市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本、印度、土耳其、墨西哥、阿根廷、波蘭俄羅斯、中國) 的靜脈瘤的目前患者數 (性別,各年齡世代) 調查分析,目前盛行率,加上危險因素,疾病診斷、預後,主要的症狀和併發症等系統性資訊

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化做患者數的方法

靜脈瘤的盛行率top line

靜脈瘤患者的特徵

靜脈瘤相關症狀

  • 逆流相關症狀
  • 皮膚相關症狀

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

線上價格資料、平台

參考文獻

附錄

目錄

image1

There are three different types of varicose veins: trunk, reticular and telangiectasia. This indication report details the prevalence of trunk varicose veins. Trunk varicose veins are near to the surface of the skin and are thick and knobbly in appearance. The vein becomes incompetent and varicosities develop when a section with poorly functioning valves allows back-flow into the vein causing build-up of blood and distension of the vein.

This report provides the current prevalent population for varicose veins across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Mexico, Argentina, Poland, Russia and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of segments affected, severity and patterns of varicose veins, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of varicose veins have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for varicose veins include:

  • Deep vein thrombosis
  • Obesity
  • Hypertension
  • Phlebitis
  • Chronic venous insufficiency
  • Venous ulcer

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global varicose veins' market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of varicose veins and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on varicose veins' prevalent population.
  • Identify sub-populations within varicose veins which require treatment.
  • Gain an understanding of the specific markets that have the largest number of varicose veins patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, IN, PL, TR, AR, RU, MX

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors and Prevention

Diagnosis of the Disease

Variation by Geography/ Ethnicity

Disease Prognosis and Clinical Course

Key Co-Morbid Conditions / Features associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Varicose Veins

Features of Varicose Veins Patients

Associated Co-morbid Conditions of Varicose Veins

  • Reflux-related Conditions
  • Skin-related Conditions

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • CEAP classification for varicose veins
  • Prevalence of varicose veins, total (000s)
  • Prevalence of varicose veins, males (000s)
  • Prevalence of varicose veins, females (000s)
  • Patterns of varicose veins in patients, total (000s)
  • Number of segments affected in patients with varicose veins, total (000s)
  • Severity of varicose veins by CEAP class in patients with varicose veins, total (000s)
  • Functional disease status of patients with varicose veins, total (000s)
  • Prevalence of GSV reflux in patients with varicose veins, total (000s)
  • Prevalence of saphenofemoral junction reflux in patients with varicose veins, total (000s)
  • Prevalence of saphenopopliteal junction reflux in patients with varicose veins, total (000s)
  • Prevalence of oedema in patients with varicose veins, total (000s)
  • Prevalence of skin changes in patients with varicose veins, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA prevalence of varicose veins by 5-yr age cohort, males (000s)
  • USA prevalence of varicose veins by 5-yr age cohort, females (000s)
  • France prevalence of varicose veins by 5-yr age cohort, males (000s)
  • France prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Germany prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Germany prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Italy prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Italy prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Spain prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Spain prevalence of varicose veins by 5-yr age cohort, females (000s)
  • United Kingdom prevalence of varicose veins by 5-yr age cohort, males (000s)
  • United Kingdom prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Brazil prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Brazil prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Japan prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Japan prevalence of varicose veins by 5-yr age cohort, females (000s)
  • India prevalence of varicose veins by 5-yr age cohort, males (000s)
  • India prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Turkey prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Turkey prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Mexico prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Mexico prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Poland prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Poland prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Argentina prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Argentina prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Russia prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Russia prevalence of varicose veins by 5-yr age cohort, females (000s)
  • China prevalence of varicose veins by 5-yr age cohort, males (000s)
  • China prevalence of varicose veins by 5-yr age cohort, females (000s)
Back to Top